Surgical management of ulcerative colitis

Swiss Medical Weekly

Volumn 131, Issue 23-24, 2001, Pages 323-337

  Kaiser, A M ^a   Beart R W , Jr ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Ileostomy; Pouch; Quality of life; Surgery; Ulcerative colitis

Indexed keywords

ANORECTAL DISEASE; ANUS TUMOR; CLINICAL FEATURE; COLON PERFORATION; COLORECTAL CANCER; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; MORBIDITY; PATIENT COUNSELING; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROCTOCOLECTOMY; RECTUM HEMORRHAGE; REVIEW; SAFETY; SURGICAL MORTALITY; SYMPTOM; TOXIC MEGACOLON; TREATMENT INDICATION; TREATMENT PLANNING; ULCERATIVE COLITIS;

EID: 0035897826     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (191)

1. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients
2. Epidemiology and the natural course of inflammatory bowel disease
3. Ulcerative colitis in Stockholm County - A study of epidemiology, prognosis, mortality and cancer risk with special reference to a surveillance program
4. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: A population-based study
5. Epidemiology of inflammatory bowel disease
6. Epidemiology of ulcerative colitis in Israel: A survey of Israeli kibbutz settlements
7. Inflammatory bowel disease in Iceland, 1990-1994: A prospective, nationwide, epidemiological study
8. Ulcerative colitis and indeterminate colitis in the city of Malmo, Sweden. A 25-year incidence study
9. Incidence of inflammatory bowel disease across Europe: Is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)
10. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: A nationwide case-control study
11. Nicotine treatment for ulcerative colitis
12. Quitting smoking could increase your risk of surgery for ulcerative colitis
13. Inflammatory bowel disease and smoking-a review
14. Inflammatory bowel disease: Re-evaluation of the diagnosis in a prospective population based study in south eastern Norway
15. Ulcerative colitis: Patterns of involvement in colorectal biopsies and changes with time
16. Endoscopic and histological patchiness in treated ulcerative colitis
17. Relationship of backwash ileitis to ileal pouchitis after ileal pouch-anal anastomosis
18. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure
19. Long term prognosis in ulcerative colitis - Based on results from a regional patient group from the county of Copenhagen
20. Free colonic perforation without dilatation in ulcerative colitis
21. Inflammatory bowel disease activity measured by Positron-emission tomography
22. Magnetic resonance imaging to distinguish the type and severity of pediatric inflammatory bowel diseases
23. An experience of ulcerative colitis. I. Toxic dilation in 55 cases
24. Toxic dilatation of colon (toxic megacolon): Etiology treatment and prognosis in 42 patients
25. Multiple organ dysfunction in ulcerative colitis
26. Toxic megacolon. An analysis of 70 cases
27. Outcome of toxic dilatation in ulcerative and Crohn's colitis
28. Current surgical approach to toxic megacolon
29. Safety of surveillance colonoscopy in long-standing ulcerative colitis
30. Acute major gastrointestinal haemorrhage in inflammatory bowel disease
31. Ulcerative colitis and colorectal cancer. A population-based study
32. Lymphoma in inflammatory bowel disease
33. Malignant lymphoma in ulcerative colitis. Report of a case
34. Risk of lymphoma in inflammatory bowel disease
35. Ulcerative colitis and Crohn's disease: A comparison of the colorectal cancer risk in extensive colitis
36. Familial predisposition for colorectal cancer in chronic ulcerative colitis: A case-control study
37. Increased risk of cancer in ulcerative colitis: A population-based cohort study
38. Therisk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis
39. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis
40. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis
41. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study
42. Colorectal cancer in patients with ulcerative colitis. A population study in central Israel
43. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: The Florence Study
44. Colon cancer in ulcerative colitis
45. Ileal pouch-anal anastomosis for chronic ulcerative colitis and familial polyposis coli complicated by adenocarcinoma
46. Carcinoma of the colon and rectum complicating chronic ulcerative colitis
47. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis
48. Benign and malignant colorectal strictures in ulcerative colitis
49. Dysplasia and cancer complicating strictures in ulcerative colitis
50. Polymyositis of the skeletal muscles as an extraintestinal complication in quiescent ulcerative colitis
51. Extraintestinal cancers in inflammatory bowel disease
52. Vascular complications of inflammatory bowel disease
53. Therapy of inflammatory bowel disease
54. Medical therapy of inflammatory bowel disease for the 21st century
55. Ulcerative colitis practice guidelines in adults
56. Medical therapy for inflammatory bowel disease
57. The modern medical management of acute, severe ulcerative colitis
58. Maintenance therapy in ulcerative colitis and Crohn's disease
59. Cyclosporine in severe ulcerative colitis refractory to steroid therapy
60. Cyclosporin for severe ulcerative colitis: A user's guide
61. Drug therapy for inflammatory bowel disease: Part II
62. Nicotine therapy for ulcerative colitis: A review of rationale, mechanisms, pharmacology, and clinical results
63. Antitumour necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
64. Novel therapies for inflammatory bowel disease
65. Are antibiotics useful in the management of nontoxic severe ulcerative colitis?
66. Emergency surgery for ulcerative colitis
67. Medical and surgical management of severe colitis
68. Toxic megacolon in ulcerative colitis: A continuing challenge
69. Toxic megacolon: Ultimate fate of patients after successful medical management
70. Safety of urgent restorative proctocolectomy with ileal pouchanal anastomosis for fulminant colitis
71. Toxic megacolon: Surgical timing important
72. Total colectomy with ileorectal anastomosis in surgical management of toxic megacolon
73. Surgical treatment of toxic megacolon. Ileostomy and colostomy to prepare patients for colectomy
74. Choice of operation for the toxic megacolon phase of nonspecific ulcerative colitis
75. Management of severe haemorrhage in ulcerative colitis
76. The surgical aspects of chronic mucosal inflammatory bowel disease (chronic ulcerative colitis)
77. Total proctocolectomy and ileostomy: Procedure of choice for acute toxic megacolon
78. Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin
79. Ulcerative colitis and colon carcinoma: Epidemiology, surveillance, diagnosis and treatment.
80. Surveillance for colonic carcinoma in ulcerative colitis
81. Surveillance in the routine management of ulcerative colitis: The predictive value of low-grade dysplasia
82. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review
83. Cancer surveillance in ulcerative colitis. Experience over 15 years
84. Clinical and colonoscopic surveillance in ulcerative colitis: Are we saving colons or saving lives?
85. Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia
86. Colorectal cancer in inflammatory bowel disease: A continuing problem
87. A decision analysis of surveillance for colorectal cancer in ulcerative colitis
88. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study
89. Screening for colorectal cancer in ulcerative colitis: Dubious benefits and high costs
90. Cancer and inflammatory bowel disease: Bias, epidemiology, surveillance, and treatment
91. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?
92. Understanding surveillance colonoscopy
93. Mucosal proctectomy and colo-anal anastomosis for distal ulcerative proctocolitis
94. Ileal pouch-anal anastomosis for chronic ulcerative colitis. Long-term results
95. Sphincter saving operations for chronic ulcerative colitis
96. Proctocolectomy and ileoanal anastomosis
97. Comparing functional results one year and ten years after ileal pouch-anal anastomosis for chronic ulcerative colitis
98. Randomized prospective trial comparing ileal pouch-anal anastomosis performed by excising the anal mucosa to ileal pouch-anal anastomosis performed by preserving the anal mucosa
99. Double-stapled vs. handsewn ileal pouch-anal anastomosis in patients with chronic ulcerative colitis
100. Functional outcome after colectomy and ileorectal anastomosis compared with proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis
101. Functional outcome of conversion of ileorectal anastomosis to ileal pouch-anal anastomosis in patients with familial adenomatous polyposis and ulcerative colitis
102. Long-term results of ileorectal anastomosis in ulcerative colitis in Stockholm County
103. Rectal preservation in nonspecific inflammatory disease of the colon
104. The fate of the rectal stump after subtotal colectomy for ulcerative colitis
105. Ulcerative colitis and coexisting colorectal cancer: Recurrence rate after restorative proctocolectomy
106. Physiology of ileal pouch-anal anastomosis. Current concepts
107. Straight ileoanal anastomosis v ileal pouch-anal anastomosis after colectomy and mucosal proctectomy
108. Consequences of ileal pouch-anal anastomosis for Crohn's colitis
109. Ileal pouch/anal anastomosis for Crohn's disease
110. Outcome of «indeterminant» colitis following ileal pouch-anal anastomosis
111. Results of restorative proctocolectomy in the elderly
112. Lengthening of the mesentery using the marginal vascular arcade of the right colon as the blood supply to the ileal pouch
113. Functional comparison between double and triple ileal loop pouches
114. Reconstruction for chronic dysfunction of ileoanal pouches
115. Restorative proctocolectomy for ulcerative colitis in children - Is the J-pouch better than straight pull-through?
116. Ileal pouchanal anastomosis without ileostomy
117. Restorative proctocolectomy without diverting ileostomy
118. Restorative proctocolectomy in children with ulcerative colitis utilizing rectal mucosectomy with or without diverting ileostomy
119. Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis
120. Complications of the ileal pouch: Is the pouchogram a useful predictor?
121. Incidence and subsequent impact of pelvic abscess after ileal pouch-anal anastomosis for chronic ulcerative colitis
122. Outcome of pouch-related complications after ileal pouch-anal anastomosis
123. Ileal pouch-anal anastomoses complications and function in 1005 patients
124. Ileal pouch-anal anastomosis. Reoperation for pouch-related complications
125. Consequences of delayed ileostomy closure after ileal pouch-anal anastomosis
126. Ileostomy
127. Ileostomy in ulcerative colitis. A questionnaire study of 1, 803 patients
128. Quality of life after proctocolectomy. A comparison of Brooke ileostomy, Kock pouch, and ileal pouch-anal anastomosis
129. Longterm ileostomy complications in patients with ulcerative colitis and Crohn's disease
130. The quality of life after proctocolectomy and ileostomy: A study of patients with conventional ileostomies converted to continent ileostomies
131. Intra-abdominal "reservoir" in patients with permanent ileostomy. Preliminary observations on a procedure resulting in faecal "continence" in five ileostomy patients
132. The continent ileostomy: Long-term durability and patient satisfaction
133. Long-term follow-up of patients with continent ileostomies
134. Factors affecting revision rate after continent ileostomy
135. Modified techniques for improving the continent ileostomy
136. Evolution of the Kock continent reservoir ileostomy
137. Technique for nipple valve fixation to prevent valve slippage in continent ileostomy
138. Afferent nipple valve malfunction caused by anchoring collar: An unexpected late complication of the Kock continent ileal reservoir
139. Construction of a stable nipple valve with processed dermal sheep collagen for continent ileostomy and urostomy
140. A new type of continent ileostomy. Results of an animal study
141. Improved results with continent ileostomy
142. T-pouch: A promising new valve design for a continent ileostomy
143. Conversion of the failing ileoanal pouch to reservoir-ileostomy rather than to ileostomy alone
144. Quality of life after Brooke ileostomy and ileal pouch-anal anastomosis. Comparison of performance status
145. Long-term functional outcome and quality of life after stapled restorative proctocolectomy
146. Operative treatment of ulcerative colitis: Conventional proctectomy with Brooke ileostomy versus mucosal proctectomy with ileoanal anastomosis
147. Obstruction after ileal pouch-anal anastomosis: A preventable complication?
148. Small intestinal obstruction complicating ileal pouch-anal anastomosis
149. Vaginal fistula following restorative proctocolectomy
150. Does technique of anastomosis play any role in developing late perianal abscess or fistula?
151. Repeat ileal pouch-anal anastomosis to salvage septic complications of pelvic pouches: Clinical outcome and quality of life assessment
152. Pouchrelated fistula following restorative proctocolectomy
153. Temporary loop ileostomy for restorative proctocolectomy
154. Indications and outcome of reoperation for ileostomy complications in inflammatory bowel disease
155. Stapled versus sutured closure of loop ileostomy: A randomized controlled trial
156. Pouchitis: Pathophysiology and treatment
157. Medical therapy for induction and maintenance of remission in pouchitis: A systematic review
158. Pouchitis: Risk factors, etiology, and treatment
159. Probiotics in chronic pouchitis: Restoring luminal microbial balance
160. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
161. Determinants of stool frequency after ileal pouch-anal anastomosis
162. Pattern of mucosal adaptation in acute and chronic pouchitis
163. Crohn's-like complications in patients with ulcerative colitis after total proctocolectomy and ileal pouch-anal anastomosis
164. "Cuffitis" and inflammatory changes in the columnar cuff, anal transitional zone, and ileal reservoir after stapled pouch-anal anastomosis
165. Anal canal inflammation after ileal pouch-anal anastomosis. The need for treatment
166. Incidence, risk factors, and treatment of dysplasia in the anal transitional zone after ileal pouch-anal anastomosis
167. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis
168. Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis
169. Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
170. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis
171. Liver transplantation and inflammatory bowel disease
172. Gynecologic history of women with inflammatory bowel disease
173. Sexual function in women after proctocolectomy
174. Sexual function after ileo-anal anastomosis
175. Ileal J-pouchanal anastomosis, sexual dysfunction, and fertility
176. Social and sexual function following ileal pouch-anal anastomosis
177. Fertility and pregnancy in inflammatory bowel disease
178. Increased risk of preterm birth for women with inflammatory bowel disease
179. Fertility and sexual and gynecologic function after ileal pouch-anal anastomosis
180. Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis
181. The effect of pregnancy and delivery on the ileal pouch-anal anastomosis functions
182. Laparoscopic restorative proctocolectomy: Case-matched comparative study with open restorative proctocolectomy
183. J ileal pouch-anal anastomosis for chronic ulcerative colitis: Complications and long-term outcome in 1310 patients
184. Functional results after perineal complications of ileal pouch-anal anastomosis
185. Ileal pouch-anal anastomosis. Patterns of failure
186. Restorative proctocolectomy with ileal reservoir: Indications and results
187. Restorative proctocolectomy with ileal pouch-anal anastomosis in 203 patients: The Auckland experience
188. Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: A ten-year experience
189. An audit of restorative proctocolectomy
190. The clinical and functional outcome after restorative proctocolectomy. A prospective study in 100 patients